Updated:
Research Corporation Technologies
Research Corporation Technologies invests in early-stage biomedical companies via venture and licensing programs from Tucson.
Research Corporation Technologies
Research Corporation Technologies was established in 1987 as a technology investment and management company. It supplies early-stage capital and development resources to biomedical companies. The firm targets early-stage and seed opportunities through venture commitments, partnerships, and special licensing arrangements. Confirmed geographic reach covers North America with emphasis on the West Coast plus partner networks in Europe, Australia, and Japan. Asset classes include biotechnology, medical devices, pharmaceuticals, and healthcare IT. No public data exist on team size, additional offices, or adjacent vehicles. No dated operational events from the last 24 months appear in available sources. The firm maintains a hybrid structure that combines direct venture investments with licensing programs rather than operating solely through fund commitments or co-investor clubs.
General information
Firm type
Private Equity
Year founded
1987
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Tucson
Corporate office
6440 North Swan Road Suite 200, Tucson, AZ, United States
Sector focus
Frequently asked questions
What investment stages does Research Corporation Technologies target?
The firm targets early-stage, seed, and start-up opportunities in addition to select expansion and late-stage deals.
Which sectors receive the majority of capital from Research Corporation Technologies?
Biotechnology, healthcare, medical devices, pharmaceuticals, and healthcare IT account for the documented focus areas.
Does Research Corporation Technologies commit to external funds or make direct investments?
Activity centers on direct venture investments, partnerships, and licensing programs rather than fund commitments.
Where does Research Corporation Technologies deploy capital geographically?
Primary deployment occurs in North America with West Coast emphasis and supporting networks in Europe, Australia, and Japan.
How does Research Corporation Technologies structure its biomedical investments?
Investments combine venture funding with development support through partnerships and special licensing arrangements.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: